Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer’s disease pathogenesis

Li Zhu,Minghao Zhong,Gregory A. Elder,Mary Sano,David M. Holtzman,Sam Gandy,Christopher Cardozo,Vahram Haroutunian,Nikolaos K. Robakis,Dongming Cai

DOI: https://doi.org/10.1073/pnas.1510011112

IF: 11.1

2015-09-08

Proceedings of the National Academy of Sciences

Abstract:Significance The apolipoprotein E4 (ApoE4) genotype is the strongest genetic risk factor for developing Alzheimer’s disease (AD). However, the mechanisms that underlie this link between ApoE4 genotype and AD are not well understood. Our data in this paper are the first mechanistic studies to our knowledge that link ApoE4 genotype-specific changes in brain phospholipid homeostasis to ApoE4-increased susceptibility to develop AD. Our studies indicate previously unidentified therapeutic options for the treatment of AD, targeting ApoE4’s pathogenic nature.